CN Patent

CN102844317B — 作为Janus激酶抑制剂的环丁烷和甲基环丁烷衍生物

Assigned to Incyte Corp · Expires 2015-06-03 · 11y expired

What this patent protects

本发明涉及环丁烷和甲基环丁烷衍生物，以及其盐类、组合物和使用方法，其为可用于治疗JAK相关疾病的Janus激酶(JAK)抑制剂，所述JAK相关疾病包括，例如，炎性和自身免疫性失调，以及癌症和骨髓增生性失调。

USPTO Abstract

本发明涉及环丁烷和甲基环丁烷衍生物，以及其盐类、组合物和使用方法，其为可用于治疗JAK相关疾病的Janus激酶(JAK)抑制剂，所述JAK相关疾病包括，例如，炎性和自身免疫性失调，以及癌症和骨髓增生性失调。

Drugs covered by this patent

Patent Metadata

Patent number
CN102844317B
Jurisdiction
CN
Classification
—
Expires
2015-06-03
Drug substance claim
No
Drug product claim
No
Assignee
Incyte Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.